Submitted:
30 August 2023
Posted:
31 August 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Statistical Analysis
3. Results
3.1. General Data
3.2. Comparative Clinical Study According to Vital Status at Discharge
3.3. Multivariate Analysis
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Tasso, C.W.; Aday, A.W.; Almarzooq, Z.I.; Alonso, A.; Beaton, A.Z.; Bittencourt, M.S.; Boehme, A.K.; Buxton, A.E.; Carson, A.P.; Commodore-Mensah, Y.; et al. Heart disease and stroke statistics-2022 Update: A report from the American Heart Association. Circulation, 2022; 145, e153–e639. [Google Scholar]
- Mencl, S.; Garz, C.; Niklass, S.; Braun, H.; Göb, E.; Homola, G.; Heinze, H.J.; Reymann, K.G.; Kleinschnitz, C.; Schreiber, S. Early Microvascular Dysfunction in Cerebral Small Vessel Disease Is Not Detectable on 3.0 Tesla Magnetic Resonance Imaging: A Longitudinal Study in Spontaneously Hypertensive Stroke-Prone Rats. Exp Transl Stroke Med. 2013, 5, 8. [Google Scholar]
- Feigin, V.L.; Lawes, C.M.; Bennet, D.A.; Barker-Collo, S.L.; Parag, V. World-wide stroke incidence and early case fatality reported in 55 population-based studies: a systematic review. Lancet Neurol 2009, 8, 355–369. [Google Scholar] [CrossRef]
- Wang, W.X.; Springer, J.E.; Hatton, K.W. MicroRNAs as Biomarkers for Predicting Complications Following Aneurysmal Subarachnoid Hemorrhage. Int J Mol Sci 2021, 22, 9492. [Google Scholar]
- Mao, R.; Zong, N.; Hu, Y.; Chen, Y.; Xu, Y. Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke. Neurosci Bull. 2022, 1–19. [Google Scholar]
- Arboix, A.; Oliveres, M.; Massons, J.; Pujades, R.; García-Eroles, L. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis. Eur J Neurol 1999, 6, 677–683. [Google Scholar]
- Kim, K.Y.; Shin, K.Y.; Chang, K.A. Potential Biomarkers for Post-Stroke Cognitive Impairment: A Systematic Review and Meta-Analysis. Int J Mol Sci 2022, 23, 602. [Google Scholar] [CrossRef]
- Cullell, N.; Gallego-Fábrega, C.; Cárcel-Márquez, J.; Muiño, E.; Llucià-Carol, L.; Lledós, M.; Martín-Campos, J.M.; Molina, J.; Casas, L.; Almería, M.; et al. ICA1L is associated with small vessel disease: A proteome-wide association study in small vessel stroke and intracerebral haemorrhage. Int J Mol Sci 2022, 23, 3161. [Google Scholar]
- Wang, W.X.; Springer, J.E.; Hatton, K.W. MicroRNAs as Biomarkers for Predicting Complications Following Aneurysmal Subarachnoid Hemorrhage. Int J Mol Sci 2021, 22, 9492. [Google Scholar]
- Giralt-Steinhauer, E.; Jiménez-Baladó, J.; Fernández-Pérez, I.; Rey, L.A.; Rodríguez-Campello, A.; Ois, A.; Cuadrado-Godia, E.; Jiménez-Conde, J.; Roquer, J. Genetics and epigenetics of spontaneous intracerebral hemorrhage. Int J Mol Sci 2022, 23, 6479. [Google Scholar]
- Díaz-Guzmán, J.; Egido, J.A.; Gabriel-Sánchez, R.; Barberá-Comes, G.; Fuentes-Gimeno, B.; Fernández-Pérez, C.; et al. Stroke and Transient Ischemic Attack Incidence Rate in Spain: The IBERICTUS Study. Cerebrovasc Dis 2012, 34, 272–81. [Google Scholar]
- Luy, M.; Gast, K. Do women live longer or do men die earlier? Reflections on the causes of sex differences in life expectancy. Gerontology 2014, 60, 143–153. [Google Scholar]
- Kobayashi, L.C.; Beeken, R.J.; Meisel, S.F. Biopsychosocial predictors of perceived life expectancy in a national sample of older men and women. Plos One 2017, 12, e0189245. [Google Scholar]
- Arboix, A.; Pizarro, P.; Fontana, S.; Massons, J.; Garcia-Eroles, L.; Comes, E.; Oliveres, M. Changing profiles of acute stroke in very old patients: Results from the Sagrat Cor Hospital of Barcelona Stroke Registry over a 24-year period. Curr Trends Neurol 2015, 9, 27–35. [Google Scholar]
- Li, M.; Liu, X.; Wang, L.; Shu, L.; Luan, L.; Yin, J.; Zhang, J.; Wang, Q.; Zhang, Y.; Xie, T.; Liu, L.; Geng, T. Admission Hemoglobin Is Prognostic for In-Hospital Mortality in Oldest-Old Patients with Acute Ischemic Stroke. Gerontology 2021, 67, 687–694. [Google Scholar] [CrossRef]
- Ministerio de Sanidad, Consumo y Bienestar Social. Portal estadístico. Área de inteligencia de gestión. Mortalidad por causa de muerte [Internet]. España: Ministerio de Sanidad, Consumo y Bienestar Social; [citado 2018 oct 30]. Available from: https://pestadistico.inteligenciadegestion.mscbs.es/publicoSNS/comun/ArbolNodos.aspx?idNodo=106.
- Orzuza, G.; Zurrú, M.C. Epidemiological aspects of stroke in very old patients. Cardiovasc Hematol Disord Drug Targets 2011, 11, 2–5. [Google Scholar] [CrossRef]
- Erbguth, F. Schlaganfallakuttherapie im Alter. Z Gerontol Geriatr 2020, 53, 59–74. [Google Scholar] [CrossRef]
- Kauffmann, J.; Grün, D.; Yilmaz, U.; Wagenpfeil, G.; Faßbender, K.; Fousse, M.; Unger, M.M. Acute stroke treatment and outcome in the oldest old (90 years and older) at a tertiary care medical centre in Germany-a retrospective study showing safety and efficacy in this particular patient population. BMC Geriatr. 2021, 21, 611. [Google Scholar] [CrossRef]
- Eaker, E.D.; Chesebro, J.H.; Sacks, F.M.; Wenger, N.K.; Whisnant, J.P.; Winston, M. Cardiovascular disease in women. Circulation 1993, 88, 1999–2009. [Google Scholar]
- Gallego Fabrega, C.; Muiño, E.; Cullell, N.; Cárcel-Márquez, J.; Lazcano, U.; Soriano-Tárraga, C.; Lledós, M.; Llucià-Carol, L.; Aguilera-Simón, A.; Marín, R.; et al. Biological Age Acceleration Is Lower in Women With Ischemic Stroke Compared to Men. Stroke 2022, 53, 2320–2330. [Google Scholar] [CrossRef]
- Bousser, M.G. Stroke in women. Circulation. 1999, 99, 463–467. [Google Scholar]
- Wong, M.C.W.; Giuliani, M.J.; Haley, E.C. Cerebrovascular disease and stroke in women. Cardiology 1990, 77 (Suppl 2), 80–90. [Google Scholar]
- Tansey, M.J.B.; Opie, L.H.; Kenelly, B.M. High mortality in obese women diabetics with acute myocardial infarction. BMJ 1977, 1, 1624–1626. [Google Scholar]
- Roquer, J.; Rodríguez, A.C.; Gomis, M. Sex differences in first-ever acute stroke. Stroke 2003, 34, 1581–1585. [Google Scholar]
- Palomeras Soler, E.; Fossas Felip, P.; Casado Ruiz, V.; Cano Orgaz, A.; Sanz Cartagena, P.; Muriana Batiste, D. The Mataró Stroke Registry: a 10-year registry in a community hospital. Neurologia 2015, 30, 283–289. [Google Scholar]
- Benjamin, E.J.; Muntner, P.; Alonso, A.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Das, S.R.; et al. ; Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019, 139, e56–e528. [Google Scholar] [CrossRef]
- Di Stefano, V.; De Angelis, M.V.; Montemitro, C.; Russo, M.; Carrini, C.; di Giannantonio, M.; Brighina, F.; Onofrj, M.; Werring, D.J.; Simister, R. Clinical presentation of strokes confined to the insula: a systematic review of literature. Neurol Sci 2021, 42, 1697–1704. [Google Scholar] [CrossRef]
- Leventis, I.; Perlepe, K.; Sagris, D.; Sirimarco, G.; Strambo, D.; Georgiopoulos, G.; Eskandari, A.; Karagkiozi, E.; Vemmou, A.; Koroboki, E.; et al. Characteristics and outcomes of Embolic Stroke of Undetermined Source according to stroke severity. Int J Stroke 2020, 15, 866–871. [Google Scholar] [CrossRef]
- Tehrani, A.S.S.; Kattah, J.C.; Kerber, K.A.; Gold, D.R.; Zee, D.S.; Urrutia, V.C.; Newman-Toker, D.E. Diagnosing stroke in acute dizziness and vertigo. Pitfalls and pearls. Stroke 2018, 49, 788–795. [Google Scholar] [CrossRef]
- Choi, J.; Lee, S.; Kim, J. Central vertigo. Curr Opin Neurol 2018, 31, 81–89. [Google Scholar] [CrossRef]
- Arboix, A.; Massons, J.; Oliveres, M.; García, L.; Titus, F. An analysis of 1000 consecutive patients with acute cerebrovascular disease. The registry of cerebrovascular disease of La Alianza-Hospital Central of Barcelona. Med Clin (Barc), 1993; 101, 281–285. [Google Scholar]
- Bejot, Y.; Catteau, A.; Caillier, M.; Rouaud, O.; Durier, J.; Marie, C.; Di Carlo, A.; Osseby, G.V.; Moreau, T.; Giroud, M. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006. A population-based study. Stroke, 2008; 39, 1945–1951. [Google Scholar]
- Rudilosso, S.; Rodríguez-Vázquez, A.; Urra, X.; Arboix, A. The Potential Impact of Neuroimaging and Translational Research on the Clinical Management of Lacunar Stroke. Int J Mol Sci 2022, 23, 1497. [Google Scholar] [CrossRef]
- Chung, J.; Marini, S.; Pera, J.; Norrving, B.; Jimenez-Conde, J.; Roquer, J.; Fernandez-Cadenas, I.; Tirschwell, D.L.; Selim, M.; Brown, D.L.; et al. Genome-Wide Association Study of Cerebral Small Vessel Disease Reveals Established and Novel Loci. Brain 2019, 142, 3176–3189. [Google Scholar]
- Grau-Olivares, M.; Arboix, A.; Junqué, C.; Arenaza-Urquijo, E.M.; Rovira, M.; Bartrés-Faz, D. Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment. Cerebrovasc Dis 2010, 30, 157–166. [Google Scholar] [CrossRef]
- Jacova, C.; Pearce, L.A.; Costello, R.; McClure, L.A.; Holliday, S.L.; Hart, R.G.; Benavente, O.R. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012, 72, 351–362. [Google Scholar]
- Rundek, T.; Tolea, M.; Ariko, T.; Fagerli, E.A.; Camargo, C. J;. Vascular Cognitive Impairment (VCI). Neurotherapeutics, 2022; 19, 66–88. [Google Scholar] [CrossRef]
- Arboix, A.; Alvarez-Sabin, J.; Soler, L.; Comité de Redacción ad hoc del Grupo de estudio de Enfermedades Cerebrovasculares de la SEN. Ictus. Clasificación y criterios diagnósticos. Neurologia. 1998, 13(Suppl 3), S3–S10.
- Societat Catalana de Neurologia. Guies mèdiques oficials de diagnòstic i tractament. En: Malalties vasculars cerebrals. Societat Catalana de Neurologia: Barcelona, 2011; 2a ed. pp. 159-240.
- Special Report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III. Stroke. 1990, 21, 637–676.
- Silver, F.L.; Norris, J.W.; Lewis, A.J.; Hachinski, V.C. Early mortality following stroke: a prospective review. Stroke 1984, 15, 492–496. [Google Scholar]
- Kumar, S.; Selim, M.; Caplan, L. Medical complications after stroke. Lancet Neurol 2010, 9, 105–18. [Google Scholar]
- Bamford, J.M.; Sandercock, P.A.G.; Warlow, C.P.; Slattery, J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989, 20, 828. [Google Scholar]
- Armitage, P. Statistical methods in medical research. Wiley: New York, USA, 1977.
- Dixon, W.J. BMDP statistical software manual. Berkeley, CA. University of California Press: Berkeley, CA, USA, 1990; pp. 300-344.
- Smirnov, M.; Destrieux, C.; Maldonado, I.L. Cerebral White Matter Vasculature: Still Uncharted? Brain. 2021, 144, 3561–3575. [Google Scholar]
- Rabinstein, A.A. Update on Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn), 2020; 26, 268–286. [Google Scholar] [CrossRef]
- Castagna, A.; Ferrara, L.; Asnaghi, E.; Colombo, V.; Rega, V.; Fiorini, G. Post-stroke dysphagia rehabilitation in the old and oldest old: outcome and relevance for discharge home. Int J Rehabil Res 2020, 43, 55–61. [Google Scholar] [CrossRef]
- Vannucchi, V.; Moroni, F.; Grifoni, E.; Marcucci, R.; Landini, G.; Prisco, D.; Masotti, L. Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke. J Thromb Thrombolysis 2020, 49, 86–93. [Google Scholar] [CrossRef]
- Lee, M.; Huang, W.Y.; Weng, H.H.; Lee, J.D.; Lee, T.H. First-ever ischemic stroke in very old Asians: clinical features, stroke subtypes, risk factors and outcome. Eur Neurol 2007, 58, 44–8. [Google Scholar] [CrossRef]
- Wang, Y.; Jing, J.; Pan, Y.; Wang, M.; Meng, X.; Wang, Y. Clinical characteristics and prognosis in oldest old patients with ischaemic stroke or transient ischaemic attack in China. Ann Palliat Med 2022, 11, 2215–2224. [Google Scholar] [CrossRef]
- Hamanaka, M.; Tanaka, E.; Yamada, T.; Kishitani, T.; Fujinami, J.; Nagakane, Y. Long-term effectiveness of anticoagulants in oldest-old stroke survivors with atrial fibrillation. J Clin Neurosci 2022, 102, 21–25. [Google Scholar] [CrossRef]
- Cocho, D.; Yarleque, S.; Boltes, A.; Espinosa, J.; Ciurans, J.; Pont-Sunyer, C.; Pons, J. Clinical Outcome of Ischemic Stroke in Old Patients Versus Oldest-Old. J Stroke Cerebrovasc Dis 2018, 27, 3657–3661. [Google Scholar] [CrossRef]
- Ayala, C.; Croft, J.B.; Greenlund, K.J.; Keenan, N.L.; Donehoo, R.S.; Malarcher, A.M.; Mensah, G.A. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995 to 1998. Stroke 2002, 33, 1197–1201. [Google Scholar]
- Ho, J.E.; Paultre, F.; Mosca, L. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women ?. Data from the Women’s Pooling Project. Stroke 2003, 34, 2812-2816.
- Soriano-Reixach, M.M.; Vivanco Hidalgo, R.M.; Ois, A.; Rodríguez Campello, A.; Roquer, J. Interaction of Sex and Diabetes on Outcome After Ischemic Stroke. Front Neurol. 2018, 9, 250. [Google Scholar] [CrossRef]
- Andersen, K.K.; Andersen, Z.J.; Olsen, T.S. Age-and gender-specific prevalence of cardiovascular risk factors in 40,102 patients with first-ever ischemic stroke: a Nationwide Danish Study. Stroke 2010, 41, 2768–2774. [Google Scholar] [CrossRef]
- Eriksson, M.; Åsberg, S.; Sunnerhagen, K.S.; von Euler, M. Sex Differences in Stroke Care and Outcome 2005-2018: Observations From the Swedish Stroke Register. Stroke 2021, 52, 3233–3242. [Google Scholar] [CrossRef]
- Paulus, J.K.; Lai, L.Y.; Lundquist, C.; Daneshmand, A.; Buettner, H.; Lutz, J.S.; Raman, G.; Wessler, B.S.; Kent, D.M. Field Synopsis of the Role of Sex in Stroke Prediction Models. J Am Heart Assoc 2016, 5, e002809. [Google Scholar] [CrossRef]
- Arboix A, Cartanyà A, Lowak M, García-Eroles L, Parra O, Oliveres M, Massons J. Gender differences and woman-specific trends in acute stroke: results from a hospital-based registry (1986-2009). Clin Neurol Neurosurg, 2014; 127, 19–24. [CrossRef]
- Chang, K.C.; Tseng, MC.; Weng, H.H.; Lin, Y.H.; Liou, C.W.; Tan, T.Y. Prediction of length of stay of first-ever ischemic stroke. Stroke 2002, 33, 2670–2674. [Google Scholar]
- Kumar, S.; Selim, M.; Caplan, L. Medical complications after stroke. Lancet Neurol. 2010, 9, 105–118. [Google Scholar]
- Tu, J.V.; Gong, Y. Trends in treatment and outcomes for acute stroke patients in Ontario, 1992-1998. Arch Intern Med 2003, 163, 293–297. [Google Scholar]
- Junttola, U.; Lahtinen, S.; Liisanantti, J.; Vakkala, M.; Kaakinen, T.; Isokangas, J.M. Medical complications and outcome after endovascular therapy for acute ischemic stroke. Acta Neurol Scand 2021, 144, 623–631. [Google Scholar] [CrossRef]
- Hung, S.H.; Ebaid, D.; Kramer, S.; Werden, E.; Baxter, H.; Campbell, B.C.; Brodtmann, A. Pre-stroke physical activity and admission stroke severity: A systematic review. Int J Stroke 2021, 16, 1009–1018. [Google Scholar] [CrossRef]
- Wise, F.M.; Harris, D.W.; Olver, J.H.; Davis, S.M.; Disler, P.B. Acute Predictors of Social Integration Following Mild Stroke. J Stroke Cerebrovasc Dis 2018, 27, 1025–1032. [Google Scholar] [CrossRef]
- Meissner, A. Hypertension and the brain: a risk factor for more than heart disease. Cerebrovasc Dis 2016, 42, 255–262. [Google Scholar]
- Appelros, P. Prediction of length of stay for stroke patients. Acta Neurol Scand 2007, 116, 15–19. [Google Scholar] [CrossRef]
- Arboix, A.; García-Plata, C.; García-Eroles, L.; Massons, J.; Comes, E. Clinical study of 99 patients with pure sensory stroke. J Neurol 2005, 252, 156–162. [Google Scholar]
- Arboix, A.; Jiménez, C.; Massons, J.; Parra, O.; Besses, C. Hematological disorders: a commonly unrecognized cause of acute stroke. Expert Rev Hematol 2016, 9, 891–901. [Google Scholar]
- Gąsecki, D.; Kwarciany, M.; Nyka, W.; Narkiewicz, K. Hypertension, brain damage and cognitive decline. Curr Hypertens Rep 2013, 15, 547–558. [Google Scholar]
- Carey, R.M.; Moran, A.E.; Whelton, P.K. Treatment of Hypertension: A Review. JAMA 2022, 328, 1849–1861. [Google Scholar] [CrossRef]
- Zonneveld, T.P.; Richard, E.; Vergouwen, M.D.I.; Nederkoorn, P.J.; de Haan, R.; Roos, Y.B.; Kruyt, N.D. Blood Pressure-Lowering Treatment for Preventing Recurrent Stroke, Major Vascular Events, and Dementia in Patients with a History of Stroke or Transient Ischaemic Attack. Cochrane Database Syst Rev 2018, 7, CD007858. [Google Scholar]


| Ischemic stroke subtypes | Alive | Dead | Total |
|---|---|---|---|
| Atherothrombotic infarct | 119 (82.1) | 26 (17.9) | 145 |
| Lacunar infarct | 81(98.8) | 1 (1.2) | 82 |
| Cardioembolic infarct | 158 (69.6) | 69 (30.4) | 227 |
| Cerebral infarcts of unknown cause | 39 (88.6) | 5 (11.4) | 44 |
| Cerebral infarctions of unusual cause | 6 (75) | 2 (25) | 8 |
| Total | 403 (79.6) | 103 (20.4) | 506 |
| Variable, coded | Alive (n=403) |
Deceased (n=103) |
P value |
|---|---|---|---|
| Cerebrovascular risk factors (%) | |||
| Hypertension Absent Present |
174 (79.1) 229 (80.1) |
46 (20.9) 57 (19.9) |
0.786 |
| Diabetes Mellitus Absent Present |
333 (80) 70 (77.8) |
83 (20) 29 (22.2) |
0.628 |
| Coronary heart disease Absent Present |
340 (79.1) 63 (82.9) |
90 (20.9) 13 (17.1) |
0.445 |
| Atrial fibrillation Absent Present |
244 (84.4) 159 (73.3) |
45 (15.6) 58 (26.7) |
0.002 |
| Congestive heart failure Absent Present |
353 (81) 50 (71.4) |
83 (19) 20 (28.6) |
0.066 |
| Previous cerebral stroke Absent Present |
363 (80.3) 40 (74.1) |
89 (19.7) 14 (25.9) |
0.282 |
| History of Transient Ischemic attack (TIA) Absent Present |
359 (80.3) 44 (74.6) |
88 (19.7) 15 (25.4) |
0.304 |
| Chronic obstructive pulmonary disease Absent Present |
381 (80.2) 22 (71) |
94 (19.8) 9 (29) |
0.216 |
| Obesity Absent Present |
385 (79.1) 18 (94.7) |
102 (20.9) 1 (5.3) |
0.169 |
| Anticoagulants Absent Present |
388 (80.2) 15 (68.2) |
96 (19.8) 7 (31.8) |
0.274 |
| Hyperlipidemia Absent Present |
346 (78.5) 57 (87.7) |
95 (21.5) 8 (12.3) |
0.084 |
| Clinical features (%) | |||
| Sudden onset Absent Present |
220 (85.6) 183 (73.5) |
37 (14.4) 66 (26.5) |
0.001 |
| Acute onset (hours) Absent Present |
279 (78.4) 124 (82.7) |
77 (21.8) 26 (17.3) |
0.273 |
| Headache Absent Present |
836 (78.6) 35 (92.1) |
100 (21.4) 3 (7.9) |
0.047 |
| Early seizures Absent Present |
399 (80) 4 (57.1) |
100 (20) 3 (42.9) |
0.310 |
| Altered consciousness Absent Present |
327 (89.3) 76 (54.3) |
39 (10.7) 64 (45.7) |
0.000 |
| Limb weakness Absent Present |
87 (88.8) 316 (77.5) |
11(11.2) 92 (22.5) |
0.012 |
| Sensory deficit Absent Present |
293 (83) 110 (71.9) |
60 (17) 43 (28.1) |
0.004 |
| Hemianopia Absent Present |
339 (81.1) 64 (72.7) |
24 (27.3) 103 (20.9) |
0.076 |
| Extrapyramidal disorders Absent Present |
391 (79.1) 12 (100) |
103 (20.9) 0 |
0.159 |
| In-hospital outcome (%) | |||
| Neurological complications Absent Present |
374 (84.8) 29 (44.6) |
67 (15.2) 36 (55.4) |
0.000 |
| Respiratory complications Absent Present |
361 (86.6) 42 (47.2) |
56 (13.4) 47 (52.8) |
0.000 |
| Digestive complications Absent Present |
391 (80.5) 12 (60) |
95 (19.5) 8 (40) |
0.052 |
| Cardiac events Absent Present |
390 (81.8) 13 (44.8) |
87 (18.2) 16 (55.2) |
0.000 |
| Hemorrhagic events Absent Present |
399 (80.8) 4 (33.3) |
95 (19.2) 8 (66.7) |
0.000 |
| Infectious complications Absent Present |
335 (84.6) 68 (61.8) |
61 (15.4) 42 (38.2) |
0.000 |
| Variable | β | SE (β) | OR (CI 95%) | p |
|---|---|---|---|---|
| Cerebrovascular risk factors and clinical features1 | ||||
| Sudden onset | 0.627 | 0.252 | 1.871 (1.143-3.065) | 0.013 |
| Altered consciousness | 1.953 | 0.245 | 7.049 (4.365-11.384) | 0.000 |
| Limb weakness | 0.757 | 0.367 | 2.132 (1.038-4.378) | 0.039 |
| Cerebrovascular risk factors, clinical features and medical complications2 | ||||
| Sudden onset | 0.680 | 0.278 | 1.974 (1.144-3.406) | 0.015 |
| Altered consciousness | 1.739 | 0.280 | 5.693 (3.290-9.850) | 0.000 |
| Neurological complications | 1.374 | 0.334 | 3.950 (2.053-7.601) | 0.000 |
| Respiratory complications | 1.752 | 0.304 | 5.765 (3.177-10.460) | 0.000 |
| Cardiac events | 1.107 | 0.503 | 3.025 (1.128-8.109) | 0.028 |
| Hemorrhagic events | 1.829 | 0.738 | 6.227 (1.466-26.440) | 0.013 |
| Cerebrovascular risk factors, clinical features, medical complications and presence of lacunar infarct3 | ||||
| Sudden onset | 0.671 | 0.281 | 1.957 (1.128-3.394) | 0.017 |
| Altered consciousness | 1.583 | 0.282 | 4.868 (2.800-8.466) | 0.000 |
| Neurological complications | 1.380 | 0.336 | 3.895 (2.017-7.521) | 0.000 |
| Respiratory complications | 1.725 | 0.305 | 5.610 (3.084-10.207) | 0.000 |
| Cardiac events | 0.987 | 0.497 | 2.709 (1.023-7.177) | 0.045 |
| Hemorrhagic events | 1.685 | 0.733 | 5.392 (1.281-22.698) | 0.022 |
| Lacunar infarct | -2.264 | 1.058 | 0.104 (0.013-0828). | 0.032 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).